Experts explain the potential for new cancer drugs and treatments
Solid start in the quest for an elusive particle
UAE officials travel to Imperial to take part in innovation diploma
Transforming molecular discovery and technology innovations for patient benefit, novel training modalities and healthcare impact
Dr Christoph Lees and his team have been awarded £2.2 million from the MRC to trial a new treatment at Imperial NHS for a potentially deadly complication that affects some twin pregnancies.
Keyhole surgery for ruptured arteries has longer-term benefits for patients.
Professor Michael Seckl leads the study on promising new treatment for rare pregnancy cancer leads to remission in patients.
Doctor complaints system could risk the health of patients and doctors.
Computational and Systems Medicine is one of our six research areas, with a wide range of interdisciplinary research it aims at developing a better understanding of human health and disease.